• Home
• FAQs
• FOIA
• Careers
• Contact
• HEAT
• Download Reader
• Twitter
• YouTube

• Home
• What's New
• Enforcement Actions
• Most Wanted Fugitives
• Spotlight Articles
• Newsroom

• Home
• Reports & Publications
• Office of Audit Services
• General Department
• Report

Audit (A-06-08-00075)

09-29-08
Review of Louisiana Bioterrorism Hospital Preparedness Program - Bureau of Emergency Medical Services

Executive Summary

The Bureau of Emergency Medical Services improperly claimed $337,000 in undocumented and unauthorized Bioterrorism Hospital Preparedness Program funds. In addition, the State agency claimed $197,000 in undocumented costs, which we are setting aside for further review by the Health Resources and Services Administration.

Complete Report

Download the complete report (PDF)

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Let's start by choosing a topic

• Compendium

  Unimplemented OIG recommendations summarized.

• FY 2013 Work Plan

  OIG projects planned for 2013.

• Semiannual Report

  Significant OIG activities in 6-month increments.

• Compliance 101

  Free educational resources.

• Advisory Opinions

  Legal opinions issued by the OIG about the application of its fraud and abuse authorities.

• Child Support Enforcement

  OIG plays a role in pursuing deadbeat parents.

• All Reports and Publications
  • Office of Audit Services
    • Administration on Aging (AoA)
    • Administration for Children and Families (ACF)
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • General Departmental
    • Health Resources and Services
      Administration (HRSA)
    • Indian Health Service (IHS)
    • National Institutes of Health (NIH)
    • Federal/State Joint Audit Initiatives
    • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Office of Evaluation and Inspections
  • Health Care Fraud and Abuse Control Program Report
  • Semiannual Reports to Congress
  • Medicaid Integrity Reports
  • Top Management & Performance Challenges
  • Compendium of Unimplemented Recommendations
  • Work Plan
  • Portfolio
  • Freedom of Information Act (FOIA)
  • Federal Register Notices
  • Regulatory Authorities
  • OIG Budget
  • Recovery Act Oversight Monthly Reports
  • Recovery Act-related Audit and Inspection Reports
• Archives
  • Office of Audit Services
    • Administration for Children and Families (ACF)
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • General Departmental
    • Health Resources and Services
      Administration (HRSA)
    • Indian Health Service (IHS)
    • National Institutes of Health (NIH)
    • Federal/State Joint Audit Initiatives
    • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Office of Evaluation and Inspections
  • Health Care Fraud and Abuse Control Program Report
  • Semiannual Reports to Congress
  • Medicaid Integrity Reports
  • Top Management & Performance Challenges
    • Management Issue 1: Implementing the Affordable Care Act
    • Management Issue 2: Preventing and Detecting Medicare and Medicaid Fraud
    • Management Issue 3: Identifying and Reducing Improper Payments
    • Management Issue 4: Patient Safety and Quality of Care
    • Management Issue 5: Integrity and Security of Information Systems and Data
    • Management Issue 6: Availability and Quality of Data for Effective Program Oversight
    • Management Issue 7: Oversight of CMS Program and Benefit Integrity Contractors
    • Management Issue 8: Ensuring Integrity in Medicare and Medicaid Benefits Delivered by Private Plans
    • Management Issue 9: Avoiding Waste in Health Care Pricing Methodologies
    • Management Issue 10: Grants Management and Administration of Contract Funds
    • Management Issue 11: Ensuring the Safety of the Nation's Food Supply
    • Management Issue 12: Oversight of the Approval, Safety, and Marketing of Drugs and Devices
    • Management Issue 13: Oversight and Enforcement of the Department's Ethics Programs
  • Compendium of Unimplemented Recommendations: Orange Book
  • Compendium of Unimplemented Recommendations: Red Book
  • Work Plan
  • Federal Register Notices
  • Regulatory Authorities
  • OIG Budget
  • Testimony & Speeches
  • Safe Harbor Regulations
  • Enforcement Action: False and Fraudulent Claims
  • Enforcement Action: Kickback and Physician Self-Referral
  • Enforcement Action: Patient Dumping
  • Enforcement Action: Select Agents and Toxins

Get Email Updates

Stay up to date on the latest OIG news and opinions